CLA Relative Valuation - Akari Therapeutics PLC

Watchlist Manager

Watchlist

Price: 0.0556 EUR Market Closed

Market Cap: €198.7m

	Akari Therapeutics PLC F:CLA	US
	Re/Max Holdings Inc NYSE:RMAX	US
A	Ananda Development PCL SET:ANAN	TH
	Lineage Inc NASDAQ:LINE	US
T	Toll Brothers Inc F:TLK	US

Multiples-Based Value

There is not enough data to reliably calculate the multiples-based value of CLA.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is relative valuation?

How is Multiples-Based Value calculated?

CLA Multiples-Based Value

Bear Case

Base Case

Bull Case

Valuation Multiples

View Details

Multiples Across Competitors

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.